165 related articles for article (PubMed ID: 25247772)
1. Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Yang X; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2014 Nov; 87():159-67. PubMed ID: 25247772
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antitumor activity of triterpenoid pyrazine derivatives from 23-hydroxybetulinic acid.
Zhang H; Wang Y; Zhu P; Liu J; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2015 Jun; 97():235-44. PubMed ID: 25984840
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Lin Y; Yao H; Jiang J; Ye W; Wu X; Xu J
Bioorg Med Chem Lett; 2015 Feb; 25(3):728-32. PubMed ID: 25529742
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of Oxygen-containing Heterocyclic Ring-fused 23-Hydroxybetulinic Acid Derivatives as Antitumor Agents.
Zhang H; Li F; Zhu P; Liu J; Yao H; Jiang J; Ye W; Wu X; Xu J
Chem Biol Drug Des; 2015 Oct; 86(4):424-31. PubMed ID: 25688519
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Med Chem; 2013 Nov; 9(7):920-5. PubMed ID: 23083117
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and mechanism studies of C-23 modified 23-hydroxybetulinic acid derivatives as anticancer agents.
Lu L; Zhang H; Liu J; Liu Y; Wang Y; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Nov; 182():111659. PubMed ID: 31491611
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of 23-hydroxybetulinic acid C-28 ester derivatives as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Molecules; 2012 Jul; 17(8):8832-41. PubMed ID: 22832884
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line.
Liu WK; Ho JC; Cheung FW; Liu BP; Ye WC; Che CT
Eur J Pharmacol; 2004 Sep; 498(1-3):71-8. PubMed ID: 15363977
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
[TBL] [Abstract][Full Text] [Related]
17. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
[TBL] [Abstract][Full Text] [Related]
18. Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo.
Zheng X; Li W; Lan Z; Yang X; Li L; Yuan Y; Xia Z; Chen X; Zhang X; Yu Y
J Pharm Pharmacol; 2015 Nov; 67(11):1593-602. PubMed ID: 26245909
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of Novel Nitrogen Heterocycle-Containing Ursolic Acid Analogs as Antitumor Agents.
Wang W; Lei L; Liu Z; Wang H; Meng Q
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832266
[TBL] [Abstract][Full Text] [Related]
20. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents.
Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y
Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]